Showing results (501-510 of 840) with videos related to
Sort By:
Pageof 84
Journal of Neurological Surgery. Part B, Skull Base|April 18, 2022
The Effect of Prescription Isodose Variation on Tumor Control and Toxicities in Stereotactic Radiosurgery for Sporadic Vestibular Schwannoma: Propensity Score-Matched Case-Control StudyAchiraya Teyateeti, Christopher S Graffeo, Avital Perry, et al.The Laryngoscope|January 13, 2011
A hemorrhagic vestibular schwannoma presenting with rapid neurologic decline: a case reportMatthew L Carlson, Colin L W Driscoll, Michael J Link, et al.Cellular Immunology|September 1, 1994
Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravisZ Y Wang, H Link, A Ljungdahl, et al.Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|August 4, 1998
[Treatment of arterial femoropopliteal obstructions with Palmaz midsize stents]S Müller-Hülsbeck, H Schwarzenberg, J C Steffens, et al.The Journal of Craniofacial Surgery|October 1, 1993
Experimental studies of DL-polylactic acid biodegradable plates and screws in rabbits: computed tomography and molecular weight lossA Tschakaloff, H W Losken, J Lalikos, et al.Cornea|July 22, 2022
Randomized Prospective Evaluation of Microblepharoexfoliation BlephEx as Adjunctive Therapy in the Treatment of ChalaziaDaniel Zhu, Rohun R Gupta, Rebecca L Stein, et al.Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|December 2, 2017
Hearing Outcomes After Stereotactic Radiosurgery for Jugular ParagangliomaNeil S Patel, Michael J Link, Colin L W Driscoll, et al.Journal of Neurological Surgery. Part B, Skull Base|July 14, 2022
Cerebrovascular Complications of Vestibular Schwannoma SurgeryTarek Rayan, Ahmed Helal, Christopher S Graffeo, et al.Cancer Immunology, Immunotherapy : CII|May 11, 1999
A phase I study of a HER2/neu bispecific antibody with granulocyte-colony-stimulating factor in patients with metastatic breast cancer that overexpresses HER2/neuV Pullarkat, Y Deo, J Link, et al.Gynecologic Oncology|June 1, 1996
A phase I study of paclitaxel and cyclophosphamide in recurrent adenocarcinoma of the ovaryE Reed, G Sarosy, E Kohn, et al.Pageof 84